NCT00582348

Completed

Physical Activity and Inactivity in Lung Cancer Survivors

Memorial Sloan Kettering Cancer Center Source

Compare

Other study identifiers

Sponsor study identifier

05-094

Secondary identifiers

Grant # CA115212

Study Type

observational

Actual enrollment (reported)

188

Locations

1 country

Sites

1

Timeline

Study Start

September 2005

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

February 10, 2020

Actual (reported)

Study Completion

February 10, 2020

Actual (reported)

Brief Summary

The purpose of this study is to learn how often lung cancer survivors exercise. We also want to learn what helps people to be active or prevents them from being active. Learning this will help us to expand services for lung cancer survivors.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 188 participants
Study completion date: February 10, 2020
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
September 2005
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
December 21, 2007
Actual (reported)
First Posted
December 28, 2007
Actual (reported)
Primary Completion
February 10, 2020
Actual (reported)
Study Completion
February 10, 2020
Actual (reported)

Last Updated: February 12, 2020
Status Verified: February 2020
Last Update Submitted: February 11, 2020

Conditions

Lung Cancer Survivors

Keywords

Lung CancerSurvivorLung

Outcome Measures

Primary Outcomes (1)

The primary outcomes of this study are physical activity levels and preferences regarding physical activity counseling and interventions
45-60 minutes

Eligibility Criteria

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Eligible lung cancer survivors will be identified by the Thoracic DMT Data Manager from the Thoracic Surgical Database.

You may qualify if:

Diagnosis of primary Stage IA or IB NSCLC;

Sponsors & Collaborators

Memorial Sloan Kettering Cancer Center
Otherlead
National Institutes of Health (NIH)
NIHcollaborator

Study Sites (1)

Memorial Sloan-Kettering Cancer Center

New York, New York, 10065, United States

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

Jamie Ostroff, PhD
Memorial Sloan Kettering Cancer Center
PRINCIPAL INVESTIGATOR

Enrollment

188 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

December 21, 2007

First Posted

December 28, 2007

Study Start

September 2005

Date type not reported

This date has not been verified as actual or estimated.

Underwent surgical resection for NSCLC at MSKCC;

From 1 to 5 years post-treatment for NSCLC prior to study recruitment;

No evidence of disease (NED) at the time of recruitment;

Can be reached by telephone;

Able to provide informed consent.

You may not qualify if:

Undergoing active antineoplastic treatment;
Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.

Contact the study team to confirm eligibility.

Primary Completion

February 10, 2020

Actual (reported)

Study Completion

February 10, 2020

Actual (reported)

Last Updated

February 12, 2020

Record last verified: 2020-02

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00582348
Data provider: ClinicalTrials.gov
Source updated: 2020-02-12
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:20:25 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations